Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib and flurbiprofen for prevention of systemic inflammation after cardiopulmonary bypass in mitral valve replacement
ChiCTR-PRC-10001046Phase 4Completed
- Sponsor
- Union Hospital
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of flurbiprofen and parecoxib in Systemic Inflammatory Response Syndrome (SIRS) (3 arms), sponsored by Union Hospital. Primary endpoints: Interleukin-6, Interleukin-8 and 2 more. Started Nov 2010; status: completed.
02
Drugs
flurbiprofenparecoxib
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on ChiCTR-PRC-10001046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-10001046.